In situ radiation sensitivity of recombinant human granulocyte colony-stimulating factor-recruited murine circulating blood and bone marrow progenitors (colony-forming unit [CFU]-Granulocyte-macrophage and CFU-megakaryocyte): Evidence for possible biologic differences between mobilized blood and bone marrow

被引:4
|
作者
Scheding, S [1 ]
Media, JE [1 ]
KuKuruga, MA [1 ]
Nakeff, A [1 ]
机构
[1] WAYNE STATE UNIV, SCH MED, DIV HEMATOL & ONCOL, DETROIT, MI 48201 USA
关键词
D O I
10.1182/blood.V88.2.472.bloodjournal882472
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Increasing evidence especially stemming from peripheral blood progenitor transplantation studies points to a possible biologic difference between mobilized blood and bone marrow progenitor cells. The objective of this study was to compare the in situ radiation sensitivity of recombinant human granulocyte colony-stimulating factor (rhG-CSF)-recruited circulating granulopoietic (blood colony-forming unit-granulocyte-macrophage [CFU-GM(blood)]) and megakaryocytopoietic (blood CFU-megakaryocyte [CFU-Meg(blood)]) progenitors, with the nonmobilized fraction remaining in the bone marrow (CFU-GM(femur) and CFU-Meg(femur)). Splenectomized male B6D2F1 mice received 50 mu g/kg/d rhG-CSF daily for 8 days to induce high levels of circulating progenitors, followed by either total body X-irradiation (TBI) or X-irradiation of the chest (CI) with 62.5, 125, 250, or 500 cGy. Progenitor cells were assayed 24 hours after irradiation. circulating CFU-GM and CFU-Meg in the blood were decreased in a dose-dependent fashion by both TBI and CI, with TBI causing greater damage than CI. Average D-0 values for TBI were 53 cGy for CFU-GM(blood) and 40 cGy for CFU-Meg(blood) D-0 values for Ci were 90 cGy for CFU-GM(blood) and 140 cGy for CFU-Meg(blood). As seen for blood progenitor cells, TBI caused a dose-dependent decrease of both CFU-GM(femur) (D-0, 136 cGy) and CFU-Meg(femur) (D-0 148 cGy). However, radiation-induced bone marrow progenitor cell kill was significantly lower when compared with blood progenitors. Despite the fact that circulating blood elements only received a fraction of the total dose administered as CI, the extent of blood progenitor kill caused by CI was higher than the effects of identical TBI doses on bone marrow CFU. The results of this study showed that rhG-CSF-recruited CFU-Meg(blood) and CFU-GM(blood) were considerably more radiosensitive than femoral progenitors, thereby providing novel evidence for a biologic difference between rhG-CSF-recruited peripheral blood progenitors and the nonrecruited bone marrow CFU. (C) 1996 by The American Society of Hematology.
引用
收藏
页码:472 / 478
页数:7
相关论文
共 50 条
  • [41] EFFECT OF STEM-CELL FACTOR (C-KIT LIGAND), GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND INTERLEUKIN-3 ON HEMATOPOIETIC PROGENITORS IN HUMAN LONG-TERM BONE-MARROW CULTURES
    LEMOLI, RM
    GULATI, SC
    STEM CELLS, 1993, 11 (05) : 435 - 444
  • [42] RECOMBINANT HUMAN INTERLEUKIN-3 AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTERED INVIVO AFTER HIGH-DOSE CYCLOPHOSPHAMIDE CANCER-CHEMOTHERAPY - EFFECT ON HEMATOPOIESIS AND MICROENVIRONMENT IN HUMAN BONE-MARROW
    ORAZI, A
    CATTORETTI, G
    SCHIRO, R
    SIENA, S
    BREGNI, M
    DINICOLA, M
    GIANNI, AM
    BLOOD, 1992, 79 (10) : 2610 - 2619
  • [43] MIXED HEMATOPOIETIC COLONY FORMATION VIA IMMATURE BLAST CELL CLUSTERS ON FETAL MESENCHYMAL CELL-LAYERS DISTINGUISHES STEM-CELLS FROM PERIPHERAL-BLOOD, CORD-BLOOD, BONE-MARROW AND BLOOD STEM-CELLS MOBILIZED BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    HARMS, B
    BURDACH, S
    GOEBEL, U
    SCHNEIDER, EM
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 55 (03) : 164 - 170
  • [44] Peripheral blood stem cells differ from bone marrow stem cells in cell cycle status, repopulating potential, and sensitivity toward hyperthermic purging in mice mobilized with cyclophosphamide and granulocyte colony-stimulating factor
    Wierenga, PK
    Setroikromo, R
    Kamps, G
    Kampinga, HH
    Vellenga, E
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (03): : 523 - 532
  • [45] RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOID CANCER - AN ECONOMIC-ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    LUCE, BR
    SINGER, JW
    WESCHLER, JM
    BUCKNER, CD
    SHEINGOLD, SH
    SHANNONDORCY, K
    APPELBAUM, FR
    NEMUNAITIS, J
    PHARMACOECONOMICS, 1994, 6 (01) : 42 - 48
  • [46] SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-3 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMA - A PHASE I/II MULTICENTER STUDY
    FAY, JW
    LAZARUS, H
    HERZIG, R
    SAEZ, R
    STEVENS, DA
    COLLINS, RH
    PINEIRO, LA
    COOPER, BW
    DICESARE, J
    CAMPION, M
    FELSER, JM
    HERZIG, G
    BERNSTEIN, SH
    BLOOD, 1994, 84 (07) : 2151 - 2157
  • [47] ULTRAVIOLET-B (UVB) IRRADIATION OF MURINE BONE-MARROW ALLOGRAFTS - STEM-CELL PROTECTION AFTER PREINCUBATION WITH RECOMBINANT INTERLEUKIN-3 (IL3), GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AND GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) ALONE OR IN COMBINATION
    HUDSON, JG
    PULLENS, R
    GODWIN, V
    PAMPHILON, D
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 818 - 818
  • [48] EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR ON THE MICE RECEIVING BONE-MARROW TRANSPLANTATION FOLLOWING LETHAL IRRADIATION - ACCELERATION OF RECOVERY OF THE PERIPHERAL-BLOOD NEUTROPHILS AND POTENTIATION OF ANTIPSEUDOMONAS RESISTANCE
    TAMURA, M
    MATSUMOTO, M
    YOSHINO, T
    MATSUBARA, S
    IMAI, N
    ONO, M
    YOKOTA, T
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (01) : 18 - 23
  • [49] INTERACTIONS OF TUMOR-NECROSIS-FACTOR WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND OTHER CYTOKINES IN THE REGULATION OF DENDRITIC CELL-GROWTH INVITRO FROM EARLY BIPOTENT CD34+ PROGENITORS IN HUMAN BONE-MARROW
    REID, CDL
    STACKPOOLE, A
    MEAGER, A
    TIKERPAE, J
    JOURNAL OF IMMUNOLOGY, 1992, 149 (08): : 2681 - 2688
  • [50] A PHASE-II STUDY OF CONTINUOUS-INFUSION RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS AN ADJUNCT TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH NON-HODGKINS-LYMPHOMA IN FIRST REMISSION
    ODAY, SJ
    RABINOWE, SN
    NEUBERG, D
    FREEDMAN, AS
    SOIFFER, RJ
    SPECTOR, NA
    ROBERTSON, MJ
    ANDERSON, K
    WHELAN, M
    PESEK, K
    RITZ, J
    NADLER, LM
    BLOOD, 1994, 83 (09) : 2707 - 2714